Third distinct omicron wave
Investigation of SARS-CoV-2 variants: technical briefings
https://www.gov.uk/government/publications/investigation-of-sars-cov-2-variants-technical-briefings
BA.5 growing 35.1% faster than Omicron subvariant BA.2
BA.5 growing 19.1% faster than Omicron subvariant BA.2
US
https://covid.cdc.gov/covid-data-tracker/#new-hospital-admissions
Increase in hospital patients, probably our best proxy
Or test positivity, (14%)
UK hospital data
https://coronavirus.data.gov.uk
https://www.nytimes.com/interactive/2021/us/covid-cases.html
Australia
https://www.sbs.com.au/news/article/the-ba-5-omicron-subvariant-is-spreading-in-australia-heres-what-you-need-to-know/uypfrn7h3
Professor Adrian Esterman, University of South Australia
Basically of those subvariants ... are all in Australia at the moment and will be competing against each other
At the moment BA.2 is the majority of cases in Australia, but BA.5 is starting to take over
Australian Influenza Surveillance Report and Activity Updates – 2022
https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-ozflu-2022.htm
147,155 official notifications
55,101 in the last 2 weeks
Influenza A, 83.4%
H1N1, 0.8%
A and B coinfections, less than 0.1%
Highest notification rates in children
Zoe data
https://health-study.joinzoe.com/data
New covid wave
https://www.youtube.com/watch?v=kWrU0lF0CF8
Cases, + 225,464
Up 40% on the week
Prevalence, one in 27
Scotland, one in 18
UK R = 1.1
BA.5 surge
Similar transmissibility as BA.2
Immune escape
More reinfections, from this year and last
No increase in deaths, a little down on the week
Hospitalisations, up 33% on the week
Individual risk is less
Increases in all age groups
Increases in all regions
Long covid
New cases, + 3,851 (more than 3 months)
Omicron, less likelihood of LC compared to delta infection
More cases overall due to sheer numbers of infections
Risk of getting LC with BA.1
One in 23 infections (more than a month)
ONS data
UK, 1.7 million infections last week
https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights
1,360,600 (1 in 40 people) in England
68,500 (1 in 45 people) in Wales
59,900 (1 in 30 people) in Northern Ireland
250,700 (1 in 20 people) in Scotland
London, 25 to 34 year olds
Antibodies, January to February 2022
Secondary school pupils 96.6%
Primary school pupils 62.4%
Dr. Rochelle Walensky
(moderna)
https://www.nytimes.com/live/2022/06/24/world/covid-19-mandates-vaccine-cases?campaign_id=185&emc=edit_yct_20220624&instance_id=64890&nl=coronavirus-tracker®i_id=110300449&segment_id=96655&te=1&user_id=0b87b8c1eea981ec0514047bbfa553ca#cdc-moderna-covid-vaccine-ages-6-17
recommending a second safe and effective vaccine for children ages 6 through 17 years
Investigation of SARS-CoV-2 variants: technical briefings
https://www.gov.uk/government/publications/investigation-of-sars-cov-2-variants-technical-briefings
BA.5 growing 35.1% faster than Omicron subvariant BA.2
BA.5 growing 19.1% faster than Omicron subvariant BA.2
US
https://covid.cdc.gov/covid-data-tracker/#new-hospital-admissions
Increase in hospital patients, probably our best proxy
Or test positivity, (14%)
UK hospital data
https://coronavirus.data.gov.uk
https://www.nytimes.com/interactive/2021/us/covid-cases.html
Australia
https://www.sbs.com.au/news/article/the-ba-5-omicron-subvariant-is-spreading-in-australia-heres-what-you-need-to-know/uypfrn7h3
Professor Adrian Esterman, University of South Australia
Basically of those subvariants ... are all in Australia at the moment and will be competing against each other
At the moment BA.2 is the majority of cases in Australia, but BA.5 is starting to take over
Australian Influenza Surveillance Report and Activity Updates – 2022
https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-ozflu-2022.htm
147,155 official notifications
55,101 in the last 2 weeks
Influenza A, 83.4%
H1N1, 0.8%
A and B coinfections, less than 0.1%
Highest notification rates in children
Zoe data
https://health-study.joinzoe.com/data
New covid wave
https://www.youtube.com/watch?v=kWrU0lF0CF8
Cases, + 225,464
Up 40% on the week
Prevalence, one in 27
Scotland, one in 18
UK R = 1.1
BA.5 surge
Similar transmissibility as BA.2
Immune escape
More reinfections, from this year and last
No increase in deaths, a little down on the week
Hospitalisations, up 33% on the week
Individual risk is less
Increases in all age groups
Increases in all regions
Long covid
New cases, + 3,851 (more than 3 months)
Omicron, less likelihood of LC compared to delta infection
More cases overall due to sheer numbers of infections
Risk of getting LC with BA.1
One in 23 infections (more than a month)
ONS data
UK, 1.7 million infections last week
https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights
1,360,600 (1 in 40 people) in England
68,500 (1 in 45 people) in Wales
59,900 (1 in 30 people) in Northern Ireland
250,700 (1 in 20 people) in Scotland
London, 25 to 34 year olds
Antibodies, January to February 2022
Secondary school pupils 96.6%
Primary school pupils 62.4%
Dr. Rochelle Walensky
(moderna)
https://www.nytimes.com/live/2022/06/24/world/covid-19-mandates-vaccine-cases?campaign_id=185&emc=edit_yct_20220624&instance_id=64890&nl=coronavirus-tracker®i_id=110300449&segment_id=96655&te=1&user_id=0b87b8c1eea981ec0514047bbfa553ca#cdc-moderna-covid-vaccine-ages-6-17
recommending a second safe and effective vaccine for children ages 6 through 17 years